Completed
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
NCT01208181
- Conditions
- Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +6 more
- Locations
-
Not specified